Vander Heide R S, Hill M L, Reimer K A, Jennings R B
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Mol Cell Cardiol. 1996 Jan;28(1):103-12. doi: 10.1006/jmcc.1996.0010.
The mitochondrial ATPase enzyme accounts for roughly 35-50% of the overall energy demand that leads to ATP depletion under conditions of severe myocardial ischemia. In larger mammalian hearts, this energy squandering action of the ATPase is modulated by an endogenous inhibitor protein. The present studies were undertaken to characterize the time course of inhibition of the mitochondrial ATPase in canine myocardium under conditions of severe regional ischemia in vivo. In addition, we determined if the energy sparing effects of ischemic preconditioning (PC) can be explained by persistent inhibition of the mitochondrial ATPase enzyme. The circumflex coronary artery was ligated for 1.5 min (n = 4), 5 min (n = 6), or 15 min (n = 5). In a separate group (n = 7), hearts were preconditioned by four 5-min periods of ischemia each followed by 5 min of reperfusion. Sub-mitochondrial particles were prepared from the sub-endocardial zone of the ischemic and non-ischemic regions and were assayed for oligomycin-sensitive ATPase activity. ATPase activity was reduced to about 79% at 1.5 min and to approximately 55% at 5 and 15 min of ischemia, relative to non-ischemic tissue from the same heart. The rate of HEP utilization slowed concurrently with the development of ATPase inhibition. In preconditioned myocardium, ATPase activity was not significantly different from control myocardium from the same heart. We conclude that the early inhibition of the mitochondrial ATPase activity slows the utilization of high energy phosphate and thereby serves as an important endogenous cardioprotective mechanism. Nevertheless, altered activity of the ATPase is not the explanation of the energy sparing effect of ischemic preconditioning.
线粒体ATP酶约占严重心肌缺血条件下导致ATP耗竭的总能量需求的35%-50%。在较大的哺乳动物心脏中,ATP酶的这种能量浪费作用受到一种内源性抑制蛋白的调节。本研究旨在描述犬心肌在体内严重局部缺血条件下线粒体ATP酶抑制的时间进程。此外,我们还确定了缺血预处理(PC)的能量节省效应是否可以通过线粒体ATP酶的持续抑制来解释。结扎左旋冠状动脉1.5分钟(n=4)、5分钟(n=6)或15分钟(n=5)。在另一组(n=7)中,心脏先进行四个5分钟的缺血预处理,随后每次再灌注5分钟。从缺血和非缺血区域的心内膜下区制备亚线粒体颗粒,并检测其对寡霉素敏感的ATP酶活性。与同一心脏的非缺血组织相比,缺血1.5分钟时ATP酶活性降低至约79%,缺血5分钟和15分钟时降至约55%。HEP利用速率随着ATP酶抑制的发展而同时减慢。在预处理心肌中,ATP酶活性与同一心脏的对照心肌无显著差异。我们得出结论,线粒体ATP酶活性的早期抑制减缓了高能磷酸的利用,从而成为一种重要的内源性心脏保护机制。然而,ATP酶活性的改变并不是缺血预处理能量节省效应的原因。